Literature DB >> 24962552

[Cutaneous squamous cell carcinoma: a review with consideration of special patient groups].

U Hillen1, M Ulrich, M Alter, J C Becker, R Gutzmer, U Leiter, A Lonsdorf, A Messerschmidt, C Ulrich.   

Abstract

The incidence of non-melanoma skin cancer (NMSC) is increasing. Squamous cell carcinoma of the skin (SCC) is a tumor of the elderly. Due to the increasing life expectancy, SCC will become more and more frequent in the future. Generally SCC has a favorable prognosis. Standard therapy is microscopically- controlled excision. Therapy of advanced and metastatic SCC is still challenging. Patients with regional lymph node metastasis have ten-year survival rates less than 20%; patients with distant metastases less than 10%. Immunosuppression has been shown to be one of the key prognostic factors for metastasis. The article reviews SCC and focusses on patients being at risk for an unfavorable course.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24962552     DOI： 10.1007/s00105-013-2734-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  50 in total

1.  A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries.

Authors:  Jeffrey R Curtis; Archana Jain; Johan Askling; S Louis Bridges; Loreto Carmona; William Dixon; Axel Finckh; Kimme Hyrich; Jeffrey D Greenberg; Joel Kremer; Joachim Listing; Kaleb Michaud; Ted Mikuls; Nancy Shadick; Daniel H Solomon; Michael E Weinblatt; Fred Wolfe; Angela Zink
Journal:  Semin Arthritis Rheum       Date:  2010-08       Impact factor: 5.532

Review 2.  Roles of the immune system in skin cancer.

Authors:  S Rangwala; K Y Tsai
Journal:  Br J Dermatol       Date:  2011-11       Impact factor: 9.302

Review 3.  Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients.

Authors:  Fiona O'Reilly Zwald; Marc Brown
Journal:  J Am Acad Dermatol       Date:  2011-08       Impact factor: 11.527

Review 4.  Milestones in photocarcinogenesis.

Authors:  Craig A Elmets; Mohammad Athar
Journal:  J Invest Dermatol       Date:  2013-07-01       Impact factor: 8.551

5.  Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients.

Authors:  David G Lott; Ryan Manz; Carl Koch; Robert R Lorenz
Journal:  Transplantation       Date:  2010-09-27       Impact factor: 4.939

Review 6.  A systematic review of worldwide incidence of nonmelanoma skin cancer.

Authors:  A Lomas; J Leonardi-Bee; F Bath-Hextall
Journal:  Br J Dermatol       Date:  2012-05       Impact factor: 9.302

7.  Cutaneous malignancies during treatment with efalizumab and infliximab: When temporal relationship does not mean causality.

Authors:  Vito Di Lernia; Cinzia Ricci
Journal:  J Dermatolog Treat       Date:  2010-07-28       Impact factor: 3.359

8.  Weekly paclitaxel for platin-resistant stage IV head and neck cancer patients.

Authors:  Juan José Grau; Miguel Caballero; Eugenia Verger; Mariano Monzó; Jose Luís Blanch
Journal:  Acta Otolaryngol       Date:  2009-11       Impact factor: 1.494

9.  Subsequent cancer in patients with chronic lymphocytic leukemia--a possible immunologic mechanism.

Authors:  M H Greene; R N Hoover; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1978-08       Impact factor: 13.506

10.  The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register.

Authors:  Louise K Mercer; Adele C Green; James B Galloway; Rebecca Davies; Mark Lunt; William G Dixon; Kath D Watson; Deborah P M Symmons; Kimme L Hyrich
Journal:  Ann Rheum Dis       Date:  2012-01-12       Impact factor: 19.103
View more
  6 in total

Review 1.  [Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin].

Authors:  M Majores; E Bierhoff
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

Review 2.  [Cutaneous squamous cell carcinoma].

Authors:  U Leiter; R Gutzmer; M Alter; C Ulrich; A S Lonsdorf; M M Sachse; U Hillen
Journal:  Hautarzt       Date:  2016-11       Impact factor: 0.751

3.  Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.

Authors:  Ralf Gutzmer; Susanne Wiegand; Oliver Kölbl; Kai Wermker; Markus Heppt; Carola Berking
Journal:  Dtsch Arztebl Int       Date:  2019-09-13       Impact factor: 5.594

Review 4.  [Non-melanoma skin cancer : Pathogenesis, prevalence and prevention].

Authors:  A Zink
Journal:  Hautarzt       Date:  2017-11       Impact factor: 0.751

5.  Induction of Tyrosine Phosphorylation of UV-Activated EGFR by the Beta-Human Papillomavirus Type 8 E6 Leads to Papillomatosis.

Authors:  Stefanie Taute; Herbert J Pfister; Gertrud Steger
Journal:  Front Microbiol       Date:  2017-11-10       Impact factor: 5.640

6.  Long noncoding RNA LINC00520 prevents the progression of cutaneous squamous cell carcinoma through the inactivation of the PI3K/Akt signaling pathway by downregulating EGFR.

Authors:  Xue-Ling Mei; Shan Zhong
Journal:  Chin Med J (Engl)       Date:  2019-02       Impact factor: 2.628
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.